Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Irum Khan"'
Autor:
Jan Philipp Bewersdorf, Blanca Boluda, David Martínez-Cuadrón, Maximilian Stahl, Nikolai A. Podoltsev, Raphael Itzykson, Ellen K. Ritchie, Brendan Yoo, Thomas Cluzeau, Emma Rabinovich, Amer M. Zeidan, Florence Rabian, Ulrich Germing, Rebeca Rodríguez-Veiga, Rory M. Shallis, Steven D. Gore, Isabel Cano, Selina M. Luger, Mikkael A. Sekeres, Christine M. McMahon, Amir T. Fathi, Irum Khan, Evelyn Acuña-Cruz, Vijaya Raj Bhatt, Judith Neukirchen, Sudipto Mukherjee, Mar Tormo, Etienne Lengliné, Emmanuel Raffoux, Pau Montesinos, Wei Wei, Gail J. Roboz, Jayadev Manikkam Umakanthan, Heiko Konig, Adam R. Miller, Andrew M. Brunner
Publikováno v:
Leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Hyperleukocytosis in acute myeloid leukemia (AML) is associated with inferior outcomes. There is limited high quality evidence to support the benefits of leukapheresis. We retrospectively collected data from patients with newly-diagnosed AML who pres
Autor:
Selina M. Luger, Ellen K. Ritchie, Steven D. Gore, David Martínez-Cuadrón, Maximilian Stahl, Pau Montesinos, Blanca Boluda, Wei Wei, Rebeca Rodríguez-Veiga, Heiko Konig, Emma Rabinovich, Rory M. Shallis, Ulrich Germing, Amir T. Fathi, Nikolai A. Podoltsev, Isabel Cano, Adam R. Miller, Raphael Itzykson, Judith Neukirchen, Evelyn Acuña-Cruz, Mikkael A. Sekeres, Jan Philipp Bewersdorf, Brendan Yoo, Christine M. McMahon, Irum Khan, Thomas Cluzeau, Sudipto Mukhereje, Mar Tormo, Florence Rabian, Gail J. Roboz, Jayadev Manikkam Umakanthan, Etienne Lengliné, Emmanuel Raffoux, Vijaya Raj Bhatt, Andrew M. Brunner, Amer M. Zeidan
Publikováno v:
Leuk Lymphoma
LEUKEMIA & LYMPHOMA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
LEUKEMIA & LYMPHOMA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Acute myeloid leukemia (AML) is frequently associated with hyperleukocytosis [white blood cell count (WBC) of >50 or >100 × 109/L at presentation] [1]. Hyperleukocytosis also predicts a higher risk...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de1a99cfad3fd8033178b8ff40c56116
https://europepmc.org/articles/PMC8273667/
https://europepmc.org/articles/PMC8273667/
Autor:
Vaibhav Agrawal, Saad Arain, Gregory S. Calip, Aysenur Esen, Kirk E. Cahill, Shawn Griffin, Olatoyosi Odenike, Ardaman Shergill, Pritesh R. Patel, Heiko Konig, Wendy Stock, Sonia Christian, Karen Sweiss, John G. Quigley, Irum Khan
Publikováno v:
Am J Hematol
Relapsed or refractory acute myeloid leukemia (R/R AML) has a poor prognosis and is best treated with salvage chemotherapy as a bridge to allogeneic stem cell transplant (alloSCT). However, the optimal salvage therapy remains unknown. Here we compare
Autor:
Santosh L. Saraf, Pritesh R. Patel, Nadim Mahmud, Karen Sweiss, David Peace, Annie L. Oh, Robert E. Molokie, Matthew Koshy, Victor R. Gordeuk, Shivi Jain, Michel Gowhari, Sally Campbell-Lee, Damiano Rondelli, John G. Quigley, Irum Khan
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:1759-1765
We report on the screening and development of haploidentical hematopoietic stem cell transplantation (HSCT) for adult patients with clinically aggressive sickle cell disease (SCD) at our institution. Of 50 adult SCD patients referred for HSCT between
Autor:
Monika J. Stankiewicz, Priya Koppikar, Brady L. Stein, Lauren Diebold, Qiang Wen, Ross L. Levine, Terra L. Lasho, Zan Huang, Sandeep Gurbuxani, Benjamin Goldenson, Ayalew Tefferi, Animesh Pardanani, Christy Finke, John D. Crispino, Rachael Schultz, Irum Khan, Jessica K. Altman, Laure Gilles
Publikováno v:
Leukemia
The majority of patients with BCR-ABL1-negative myeloproliferative neoplasms (MPN) harbor mutations in JAK2 or MPL, which lead to constitutive activation of the JAK/STAT, PI3K, and ERK signaling pathways. JAK inhibitors by themselves are inadequate i